Table 5 Predictors* of arterial, venous and total thrombosis in univariate analysis.
From: Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
 | Arterial thrombosis (n = 30) | Venous thrombosis (n = 28) | ||
---|---|---|---|---|
Variables | HR (95% CI) | P value | HR (95% CI) | P value |
Male sex |  |  | 0.49 (0.22–1.09) | 0.079 |
Age, years | 1.04 (1.01–1.07) | 0.004 |  |  |
 ≥60 years | 2.01 (0.96–4.21) | 0.062 | ||
 ≥65 years | 2.88 (1.37–6.05) | 0.005 | ||
Previous thrombosis |  |  | 3.06 (1.41–6.64) | 0.005 |
 Arterial |  |  |  |  |
 Venous |  |  | 5.53 (2.32–12.2) | <0.0001 |
Leukocyte count ≥10×109/L | 2.43 (1.11–5.31) | 0.026 |  |  |
CV risk factorsa (at least 1) | 2.16 (1.01–4.62) | 0.047 |  |  |
Driver mutations | Â | Â | Â | Â |
 JAK2V617F | 3.35 (1.15–9.74) | 0.027 |  |  |
Nondriver mutations | Â | Â | Â | Â |
 EZH2 | 10.1 (1.03–99) | 0.047 |  |  |
 HMR | 13.1 (1.34–127) | 0.027 |  |  |